NCT05411640

Brief Summary

The aim of this study is to determine the effects of blood flow restriction training on glycemic control and functional activity in participants with prediabetes. Moreover, This study determine the effects of blood flow restriction training on quality of life in participants with prediabetes

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 6, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 9, 2022

Completed
22 days until next milestone

Study Start

First participant enrolled

July 1, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

February 21, 2025

Status Verified

February 1, 2025

Enrollment Period

5 months

First QC Date

June 6, 2022

Last Update Submit

February 20, 2025

Conditions

Keywords

Prediabetic StateGlycemic Control

Outcome Measures

Primary Outcomes (3)

  • Fasting Blood Sugar Level

    This measures your blood sugar after an overnight fast (not eating). A fasting blood sugar level of 99 mg/dL or lower is normal, 100 to 125 mg/dL indicates you have prediabetes, and 126 mg/dL or higher indicates you have diabetes.

    16th week

  • Hemoglobin A1c (HbA1c) test

    ,A hemoglobin A1c (HbA1c) test measures the amount of blood sugar (glucose) attached to hemoglobin. An HbA1c test may be used to check for diabetes or prediabetes in adults. The Centers for Disease Control (CDC) recommends that adults over the age of 45 get tested to screen for diabetes and prediabetes. HbA1c results are given in percentages. Typical results for this test are Normal value of HbA1c below 5.7%, for prediabetes, HbA1c between 5.7% and 6.4%, for diabetes, HbA1c of 6.5% or higher.

    16th week

  • Australian type 2 diabetes risk assessment tool (AUSDRISK)

    The Australian type 2 diabetes risk assessment tool (AUSDRISK) is a short list of questions. It helps both health professionals and individuals to assess the risk of a person developing type 2 diabetes over the next 5 years. It consists of 10 questions with each question containing 2 options. Individuals who score 5 or less than 5 are at low risk. Individuals who score 6 to 11 are at intermediate risk of developing diabetes. While, Individuals who score 12 or more are at high risk of developing diabetes

    16th week

Secondary Outcomes (5)

  • World Health Organization Quality of Life

    16th week

  • 36-Item Short Form Survey

    16th week

  • International Physical Activity Questionnaires

    16th week

  • Rockport Walking Fitness Test

    16th week

  • Borg rating of perceived exertion

    16th week

Study Arms (3)

Aerobics with Blood flow restriction

EXPERIMENTAL

This group will perform Aerobic exercises with Blood Flow Restriction training, patient education and dietary modifications will be given for pre diabetes

Other: Aerobic exercise with Blood flow restriction

Aerobics without Blood flow restriction

ACTIVE COMPARATOR

This group will perform Aerobic exercises without Blood Flow Restriction training, patient education and dietary modifications will be given for pre diabetes.

Other: Aerobic exercise without Blood flow restriction

Education and Dietary modifications

OTHER

This group will only receive education and dietary modifications for Pre-diabetes.

Other: Patient Education and dietary modification

Interventions

Experimental group will be given aerobic exercises with blood flow restriction training. For first four weeks, aerobic exercise will be performed for 25 min with 60-65 % of the maximum heart rate reserve (MHRR). During second four weeks, time of exercise will be 30 min with intensity 60-65% of the MHRR, and for third four weeks, time will be increased to 35 min and intensity will be raised up to 70-75% of the MHRR. . Arterial occlusion of 60% will be achieved by Blood Flow Restriction apparatus. Total intervention protocol for this group will be given for 12 weeks of duration 4 sessions per week with total 48 sessions.

Aerobics with Blood flow restriction

Active Comparator group will be given aerobic exercises. For first four weeks, aerobic exercise will be performed for 25 min with 60-65 % of the maximum heart rate reserve (MHRR). During second four weeks, time of exercise will be 30 min with intensity 60-65% of the MHRR, and for third four weeks, time will be increased to 35 min and intensity will be raised up to 70-75% of the MHRR. Total intervention protocol for this group will be given for 12 weeks of duration 4 sessions per week with total 48 sessions.

Aerobics without Blood flow restriction

Participants will individually instruct to reduce total energy intake and increase physical activity, aiming at a 5% reduction in body weight. The participants will be given pamphlets providing general information on pre diabetes and dietary modifications. Total intervention protocol for the group will be given for 12 weeks of duration 4 sessions per week with total 48 sessions.

Education and Dietary modifications

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Both male \& female participants
  • Age group between 30 to 60 years.
  • Subjects clinically diagnosed with prediabetes (41-49 mmol/mol) after fasting blood sugar (110-125 mg/dl) and Hb1Ac (5.7%-6.4%) or assessed using the diabetes risk assessment tool as having high risk of developing diabetes in the next five years.
  • Mean BMI for participants will be more than 22.
  • Subjects able to understand simple instructions, independently or with assistance from their support person.

You may not qualify if:

  • History of any cardiovascular problems that limited safe participation in aerobic or resistance exercise.
  • Subjects who are unable to walk 30 min independently with or without a walking aid
  • History of any psychological disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmad Poly care clinic, Faislabad

Faisalābad, Punjab Province, 54000, Pakistan

Location

MeSH Terms

Conditions

Prediabetic State

Interventions

ExercisePatient Education as TopicDiet Therapy

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaHealth EducationPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesNutrition TherapyTherapeutics

Study Officials

  • Muhammad Salman Bashir, Ph.D

    Riphah International University

    PRINCIPAL INVESTIGATOR
  • Muhammad Abbas

    Riphah International University , QIE, Campus

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2022

First Posted

June 9, 2022

Study Start

July 1, 2022

Primary Completion

December 1, 2022

Study Completion

December 1, 2023

Last Updated

February 21, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations